Celldex Therapeutics
CLDX
#4622
Rank
โ‚ฌ1.96 B
Marketcap
25,00ย โ‚ฌ
Share price
-1.93%
Change (1 day)
15.70%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): -3,74ย โ‚ฌ

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -3,97ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -3,55ย โ‚ฌ a decrease over its 2024 EPS that were of -2,23ย โ‚ฌ.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,74ย โ‚ฌ5.53%
2025-3,55ย โ‚ฌ58.78%
2024-2,23ย โ‚ฌ
2022-2,18ย โ‚ฌ45.73%
2021-1,50ย โ‚ฌ-23.36%
2020-1,95ย โ‚ฌ-41.05%
2019-3,31ย โ‚ฌ-76.95%
2018-14,36ย โ‚ฌ
2016-17,23ย โ‚ฌ-3.82%
2015-17,91ย โ‚ฌ-0.76%
2014-18,05ย โ‚ฌ
2012-13,95ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,65ย โ‚ฌ-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
15,84ย โ‚ฌ-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,62ย โ‚ฌ-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-4,00ย โ‚ฌ 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,66ย โ‚ฌ-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,84ย โ‚ฌ-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-4,59ย โ‚ฌ 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA